Rectify Pharmaceuticals Appoints Robert Hughes as Executive Vice President, Drug Discovery and Precl

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Rectify Pharmaceuticals, Inc., (“Rectify”) a biotechnology company developing small molecule disease-modifying therapeutics that restore and enhance ABC transporter function, continues to grow its senior leadership team. Robert Hughes, Ph.D., recently joined as Executive Vice Presi...

Related Keywords

Cambridge ,Cambridgeshire ,United Kingdom ,Massachusetts ,United States ,Sarah Sutton Michael Barron ,Rajesh Devraj ,Xiaobing Li ,Eli Lilly ,Robert Hughes ,Development Officer ,Preclinical Development ,Alkermes ,Ironwood Pharmaceuticals ,Global Program Leader For Zulresso ,Janssen Pharmaceutical Companies ,Pfizer ,Clover Pharmaceuticals ,Atlas Venture ,Head Of Program Leadership ,Rectify Pharmaceuticals Inc ,Longwood Fund ,Rectify Pharmaceuticals ,Executive Vice President ,Drug Discovery ,Chief Development ,Chief Executive ,Chief Development Officer ,Positive Functional Modulators ,Vice President ,Molecular Discovery ,Chief Portfolio Officer ,Program Leadership ,Portfolio Management ,Senior Director ,Global Program Leader ,Omega Funds ,Forbion Capital Partners ,